Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin.
about
General anesthetics and β-amyloid proteinPeri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesiaSubcellular Energetics and Metabolism: Potential Therapeutic Applications.Physiology and pharmacology of myocardial preconditioning.The influence of rapamycin on the early cardioprotective effect of hypoxic preconditioning on cardiomyocytesGeneral anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain.Isoflurane induces endoplasmic reticulum stress and caspase activation through ryanodine receptorsThe potential dual effects of anesthetic isoflurane on hypoxia-induced caspase-3 activation and increases in β-site amyloid precursor protein-cleaving enzyme levels.Isoflurane reduces hypoxia/reoxygenation-induced apoptosis and mitochondrial permeability transition in rat primary cultured cardiocytes.RNA interference-mediated silencing of BACE and APP attenuates the isoflurane-induced caspase activation.Pharmacological postconditioning with sevoflurane after cardiopulmonary resuscitation reduces myocardial dysfunction.Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane.Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats.The potential dual effects of anesthetic isoflurane on Aβ-induced apoptosis.Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window.Hypoxia inducible factor 1 (HIF-1) and cardioprotection.Exploring the modulation of hypoxia-inducible factor (HIF)-1α by volatile anesthetics as a possible mechanism underlying volatile anesthetic-induced CNS injury.The role of HIFs in ischemia-reperfusion injury.The genetics of isoflurane-induced developmental neurotoxicity.Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury.Isoflurane reduces oxygen-glucose deprivation-induced oxidative, inflammatory, and apoptotic responses in H9c2 cardiomyocytes.Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke.Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1.Differential effects of pharmacological HIF preconditioning of donors versus recipients in rat cardiac allografts.Age-associated differences in response to sevoflurane postconditioning in rats.Hypoxia inducible factor-1α is involved in the neurodegeneration induced by isoflurane in the brain of neonatal rats.Comparison of volatile anesthetic-induced preconditioning in cardiac and cerebral system: molecular mechanisms and clinical aspects.Rapamycin protects cardiomyocytes against anoxia/reoxygenation injury by inducing autophagy through the PI3k/Akt pathway.Isoflurane‑induced postoperative cognitive dysfunction is mediated by hypoxia‑inducible factor‑1α‑dependent neuroinflammation in aged rats.
P2860
Q27010208-4C083DD4-F285-45DC-A9D6-17986F532BEAQ28085567-7383C2CE-8294-41DB-9C22-D090F8BA8621Q30253000-3DB0F562-3E30-4B24-8231-115112596720Q30450862-09D78E0B-60BE-40C1-83B9-C87E954C173BQ33897336-ACBD1194-2BC5-48C5-877F-F3258387969CQ34117531-A6DA11A1-95A0-4EC6-A810-55B4589CF572Q34201652-EB2A9C30-DE46-40DB-B7A8-1DB3A114E37CQ35068838-940FEE71-2D4C-4DB6-81D8-7CB79CC1900BQ35115714-CC159393-3D3F-4997-B1C3-31CEE668FF7EQ35321097-01BA0205-C823-4784-82BD-DF0DFFABF9C1Q35908259-F1B5185E-48C8-4F2A-9DB2-E689EEF1FC78Q37343251-BBD9D00E-F6B9-4A0C-B1FD-F1D089EECFB5Q37449283-09A5A8A0-756C-4715-91CE-BF792172862AQ37679857-0952C78C-DF19-46B8-B8F5-9657C8926946Q37733614-8C79964D-C3CE-4261-90BC-3C3B4502ADECQ37780103-92DA9002-5670-47B7-95E7-DBB8EF83CB7BQ38227466-B816A159-225B-465F-AB78-132E1C8150BDQ38989135-73A0FBF6-3500-4160-970B-CA1DBC1AD0D6Q39090716-8F5D2DE9-4E09-4ED3-80BE-01241C78FDCCQ40003585-49005581-29ED-41F5-B54A-EE7696187C72Q42068594-F66E2BB7-5AB9-497F-9CFC-5056B63C319FQ44215971-487AF659-DD3C-432E-9FE6-CD80C9571F0CQ44409387-CFEC3AF3-DCAB-4D17-AC00-DF806B120BB9Q45777435-8FB1B698-DCD0-4692-A444-A3BC378291EBQ47616136-4E92C663-CAEE-4E28-B537-89826A3673D8Q48212753-483C6DA0-768C-40B7-909F-C882E1EE1552Q49843123-69E3679D-4612-426B-A87B-87D210BF9C6BQ53611960-6938B654-30BA-4A8B-945F-2041250C03C6Q55279075-8667870C-78C5-4169-BE81-331593C96CB5
P2860
Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Isoflurane preconditioning dec ...... mammalian target of rapamycin.
@ast
Isoflurane preconditioning dec ...... mammalian target of rapamycin.
@en
type
label
Isoflurane preconditioning dec ...... mammalian target of rapamycin.
@ast
Isoflurane preconditioning dec ...... mammalian target of rapamycin.
@en
prefLabel
Isoflurane preconditioning dec ...... mammalian target of rapamycin.
@ast
Isoflurane preconditioning dec ...... mammalian target of rapamycin.
@en
P2093
P1433
P1476
Isoflurane preconditioning dec ...... mammalian target of rapamycin.
@en
P2093
Jacob Raphael
Ronen Beeri
Suzan Abedat
Yaacov Gozal
P304
P356
10.1097/ALN.0B013E318164CAB1
P407
P577
2008-03-01T00:00:00Z